Hedge Fund - Great Point Partners
Travere Therapeutics Inc ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q3 (2023-09-30) | $0 | 0% | 0 | $ |
| 2 | 2023 - Q2 (2023-06-30) | $921,600 | 0.18% | 60,000 | $ |
| 3 | 2023 - Q1 (2023-03-31) | $22,557,470 | 4.42% | 1,003,000 | $ |
| 4 | 2022 - Q4 (2022-12-31) | $9,989,250 | 1.95% | 475,000 | $ |
| 5 | 2022 - Q3 (2022-09-30) | $23,805,000 | 5.73% | 966,108 | $ |
| 6 | 2022 - Q2 (2022-06-30) | $23,533,000 | 5.64% | 971,233 | $ |
| 7 | 2022 - Q1 (2022-03-31) | $26,028,000 | 6.29% | 1,010,000 | $ |
| 8 | 2021 - Q4 (2021-12-31) | $24,832,000 | 5.51% | 800,000 | $ |
| 9 | 2021 - Q3 (2021-09-30) | $15,156,000 | 3.52% | 625,000 | $ |
| 10 | 2021 - Q2 (2021-06-30) | $15,820,000 | 3.31% | 1,084,300 | $ |
| 11 | 2021 - Q1 (2021-03-31) | $14,825,000 | 3.06% | 593,712 | $ |
The displayed share prices are average quarterly stock market prices.